Aura Biosciences, Inc.
Aura Biosciences, Inc. (AURA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AURA · as of Jun 8, 2026
Key Statistics
Explore Aura Biosciences, Inc. Data
aura stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
The AURA analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +156.41% upside from the current price of $6.63.
Competitors & Peers
aura competitorsAURA
ALT
ANNX
DBVT
DSGN
ENGNStock Performance
Full HistoryAbout Aura Biosciences, Inc.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of hi…
what is aura biosciences, inc. · aura stock overview · aura biosciences, inc. company profile · who is aura biosciences, inc. ceo · aura NASDAQ · aura biosciences, inc. headquarters · aura biosciences, inc. business segments
About Stock Overview & Key Data
Aura Biosciences, Inc. (AURA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 29, 2021. As of the latest trading session, AURA stock price is $6.63, with a market capitalization of $425.6M. The stock has returned +5.41% over the past 12 months and +21.65% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Aura Biosciences, Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Aura Biosciences, Inc. reported revenue of — and net income of -$106.2M. For detailed data — including Aura Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aura Biosciences, Inc. (AURA) stock price is $6.63. The stock is traded on NASDAQ under the ticker symbol AURA. The 52-week range is $4.73 – $9.54.